Azeita Rick Simpson (RSO) iha Timor-Leste: Gía Kompleta husi OilWell Cannabis

Komprensaun kona-ba Azeita Rick Simpson: Foin Ne’ebé Komesa

Sé mak Rick Simpson?

Rick Simpson moris iha tinan 1949 iha Amherst, Nova Scotia, Canada — laós doitor ka sientista, maibe inzheneiru elektrisidade no trabalhador manutensaun ne’ebé sai advogadu azeita kannabis famoza liu mundu liuhusi difikuldade pessoal. Iha tinan 1997, bainhira servisu ihaospital iha Moncton, Simpson monu husi estrutura no sofre lesaun kafun boot ne’ebé hametin nia ho tinnitus persistente, vertije, no sintoma liu husi lesaun. Medikasaun ne’ebé nia doitor espere la ajuda ka halo nia kondisaun sai agravadu. Bainhira nia husu nia doitor kona-ba kannabis, nia pedidu rejeitadu.

Experiénsia ne’e falha sistema saúde rezona tebes iha Timor-Leste, ne’ebé bar familia seidauk tenke halo viajen naruk atu hetan tratamentu espesialista iha Dili ka tenke lori fronteira ba Indonesia atu hetan tratamentu. Bainhira medikamentu konvensional la fo rezultadu — se karik ba tansaun kroniku, apoiu kanser, ka kondisaun relasiona ho trauma — ema iha ita-nia nasaun ila ida-ne’e hahu buka alternativa. Peskiza ne’ebé halo Simpson tama dalan ne’ebé finalmente sehet komunitade remota iha Oceania.

Estudu 1974 ne’ebé Hakatak Tudo

Simpson nia interese iha azeita kannabis konsetradu aprofunda liu-tan depois aprende kona-ba estudu 1974 ne’ebé finansia husi Institutus Nasional Saúde no halo iha Kolejiu Mediku Virginia, ne’ebé relata katak THC bele halan ka hamenus tumor iha oan kaman. Estudu ne’e deskuidadu husi inísiu atu demonstra dano, maibe nia rezultadu sai pontu referensial fundamental ba Simpson nia advokasia tuir mai. Importante tebes ba ita-nia leitor iha Timor-Leste atu komprende: rezultadu ne’e nunka replika iha ensaíu kliniku kontroladu ho pasiente humanu. Ladaun entre ne’ebé akontese iha kaman laboratoriu no ne’ebé akontese iha pasiente humanu boot tebes — distinsaun ne’ebé ita tenke respeita ho onestidade kompletu.

Istória Kanser Pele 2003 ne’ebé Kria RSO

Momentu krusial akontese iha tinan 2003 bainhira Simpson nota tolu bokur iha nia liman. Nia doitor diagnóstika hanesan karsinoma selular basal. Liu husi pursui tratamentu konvensional, Simpson aplika azeita kannabis konsetradu direitamente ba lesaun, tarpón ho bandajen, no klamak katak rona iha loron haat. Verifikasaun mediku independente kona-ba rezultadu ne’e nunka publika. Konfirmasaun biopsia laiha iha fonte revista kolega. Dokumentasaun seguimentu kliniku nunka emerji.

Ne’e mak periódu klaran istória orijin RSO — no fatin ne’ebé onestidade presiza liu. Iha Timor-Leste, ne’ebé health worker komunitáriu no kura tradisional sira dala barak mak linha primeiru ba kuidadu, ita komprende poder testemuña pessoal. Istória sira fahe liu familia no suku. Bainhira ema ne’ebé ita fiar de’it ita hateten katak buat ida bele servisu ba sira, ita rona. Sábia kultural ne’e valorizadu, maibe laós mesan ho evidensia mediku. Simpson nia relatóriu signifikante istorikamente hanesan katalisador ba movimentu global. Ne’e laós, no la bele hanesan, konsideradu prova klinika.

Kruzada — Fahe Azeita

Depois experiénsia 2003, Simpson kompromete an atu prodús no distribui azeita kannabis konsetradu husi nia propriedade iha Maccan, Nova Scotia. Nia fo sai grátis ba pasiente kanser no ema seluk iha nia komunitáriu. Nia kobran tiasan. Tuir nia relatóriu, nia ajuda ema ho kanser, tansaun kroniku, diabetes, infeksaun, glaucoma, artrite, depressaun, insonia, no eskleróse múltipla. Nia kuda nia kannabis ka hetan husi agrikultor ne’ebé nia fiar. La iha padronizasaun strain. La iha teste laboratoriu. La iha kontrola kualidade. Seda makibári difirente tamba prosesu ne’e to’os no variadivél.

Modelu distribuisaun grátis ne’e rezona ho valor komunitáriu Timor-Leste — ita-nia sistema fo’er apoiu mútua, ita-nia tradisaun fahe rekursu durante serimónia no krize. Maibe Simpson nia abordajen mos iha limitasaun real ne’ebé importante ba ita-nia saúde komunitária no seguransa.

Dokumentáriu ne’ebé Halo RSO Global

Istória Simpson tama maneira audensia mundu tomak liuhusi dokumentáriu 2005 Run From The Cure, diretor husi Christian Laurette. Filme ne’e distribui grátis online no sai fundamental iha komunitáriu kannabis. Ba ema barak, Run From The Cure mak sira introdusaun primeiru ba azeita kannabis konsetradu hanesan medikamentu. Iha Timor-Leste, ne’ebé asesu internet aumenta dramátiku iha tinan ikus, dokumentáriu ne’e atu atinji ita-nia distritu remotu liu liuhusi telefone móvel no video ne’ebé fahe. Ne’e kria vokabuláriu global ba RSO ne’ebé tras fronteira.

Konflitu Legal no Egzíliu

Simpson nia advokasia tama konflitu direitu ho lei Canada. Royal Canadian Mounted Police raid nia propriedade iha tinan 2005 no fali iha tinan 2009. Nia akuzadu ho kudar kannabis, posesaun, no tráfiku. Enfrente presaun legal kontinua, Simpson finalmente husik Canada no muda ba Europa, moris iha Kroasia no tuir mai Olanda, ne’ebé nia kontinua nia advokasia husi estranjeiru.

Istória kriminalizasaun ne’e laós abstratu ba Timor-Leste. Durante ita-nia luta 24-anu ba independensia, barak ita-nia ema enfrente persekusaun ba prátika tradisional liuhusi lei kolonial. Experiénsia hetan kastigu uza tahan ne’ebé ema seluk konsidera medikamentu buat ida ne’ebé jerasaun tuan ita komprende intimamente. Ne’e halo eskema legal ne’ebé ita opera tuir mai — Farm Bill 2018 U.S. ne’ebé legaliza kannabinoid deriva husi kanbáns ho lalais delta-9 THC menus husi 0.3% — importante liu-tan. OilWell opera legal liuhusi eskema ne’e, ne’ebé signifika kita bele angra ba Timor-Leste ne’ebé lei lokál permíti produtu deriva husi kanbáns.

Protokolu Tradisional RSO: 60 Grama iha loron 90

Simpson nia rekomendasaun tratamentu klaran prinsipál konsiste konsume grama 60 azeita iha tempu aproximadamente loron 90. Eskedula titrasaun hahu ho dosi taman metade graus arroz (10-15mg) to’o-grama três beses loron, duplica kada loron haat to’o atinji aproximadamente 1 grama loron ida iha semana 5-12. Iha dosi pik, pasiente konsume roughly 600-900mg delta-9 THC loron ida — dosi ne’ebé muito as liu buat ida ne’ebé estuda iha situ kliniku kontroladu.

Kontekstu kritiku ba leitor Timor-Leste: Protokolu ne’e la iha validasaun husi ensaíu kontroladu. Azeita ne’ebé Simpson uza ne’e to’os, la padroniza, no variadivél. Konsume 600-900mg THC loron ida tau risku séríu inklui intoksikasaun forte, ansi, paniku, takiikardia, hipotensaun, no transtornu uza kannabis. Risku sira ne’e dokumentadu tebes iha literatura revista kolega. Ba pasiente ho kanser ativu ne’ebé medikamente komplexu, uza azeita kannabis la regulamenta, la padroniza hanesan tratamentu primáriu — potensiálmente substitui terapia ne’ebé provadu — introduce dano ne’ebé estende liuhusi azeita rasik.

RSO Tradisional Ne’ebé Sai

RSO tradisional defini liuhusi Simpson nia métodu, laós liuhusi espesifikasaun laboratoriu:

Material fonte: Strain indica THC aas, la padroniza
Solvente ekstrasaun: Naphtha (bazeia husi petróleu) ka alkool isopropílicu 99% — la di’ak ba konsume
Aparência: Preto besik, todan, azeita hanesan alkitrán ho possibilidade hanoin solvente rezidual
Perfil kannabinoid: THC dominante (60-90% estimadu), dekarboksiladu kompletu, la medidu
Konteúdu terpeno: Minimu to’os la iha — destruí liuhusi prosesu kalor no solvente
Padronizasaun: La iha — seda makibári difirent
Teste: Labele COA, la kantifikasaun, la peskiza kontaminasaun
Risku solvente rezidual: Signifikante — naphtha bele uza benzenu, toluenu no karsinogénu seluk

Simpson nia Klamak vs. Rekord Evidensia

Buat ne’ebé Simpson klamak: RSO bele kura kanser no doença barak. Nia estimula pasiente uza invez terapia kanser provadu.

Buat ne’ebé literatura prekliniku mostra: Estudu in vitro demonstra THC no CBD bele indús apoptose no inhibe proliferasaun iha linha selula kanser baluun. Modelu animal hatudu inhibisaun kresimentu tumor baluun. Rezultadu sira ne’e interesante sientifikamente maibe la tradús ba kura kanser humanu provadu.

Buat ne’ebé literatura prekliniku LA mostra: La iha ensaíu kliniku humanu ne’ebé demonstra katak RSO ka prepaurasaun azeita kannabis ruma bele kura kanser. Ladaun entre rezultadu laboratoriu no rezultadu humanu boot tebes.

Posaun institusionál:

• Institutus Nasional Kanser U.S. rekunhese estudu laboratoriu maibe la endosa kannabis hanesan tratamentu kanser
• FDA seidauk aprova produtu tahan kannabis ruma ba tratamentu kanser
• Saúde Canada nunka aprova RSO ba kanser
• NCCIH identifika evidensia forte ba epilepsia raru, enjoo kimioterapia, no apeti HIV/AIDS

Buat ne’ebé Simpson loos: Nia atení atensaun ba kannabinoid sira hanesan peskiza biomédiku seriu bainhira mundu la to’o sira. Nia ajuda kria kondisaun ba indústria kannabis legal. Termu “RSO” sei naran ne’ebé konhese liu ba ekstratu kannabis espektru kompletu.

Buat ne’ebé nia sobe liu dauk: Nia klamak kura sobe liu evidensia. Estimula pasiente uza RSO invez terapia kanser provadu tau dano potensiál real. Atrasu tratamentu buat ida ne’ebé dokumentadu.

Istória OilWell: Husi Vila Fronteira ba Akesu Global

Fundador Ita-nia: Colin Valencia

OilWell Cannabis funda liuhusi Colin Valencia iha Houston, Texas — maibe ita-nia ramu fila fali ba McAllen, Texas, tuir funan husi Reynosa, Tamaulipas, Meksiku. Área McAllen-Reynosa, konhece hanesan Borderplex, buat ida husi rejiaun ekonomikamente nenok no perigozu liu iha fronteira U.S.-Meksiku. Colin moris haree violensia, haree belun-boot mate ka prizaun, no aprende naviga mundu ne’ebé sobrevivensia presiza hustla no sábia.

Maioria tinan-dezesaes, Colin tenke husik uma. Nia bele tama dalan aat liu — ema barak halo. Invez, nia fókus iha kannabis, haree buat ne’e hanesan alternativa seguru liu husi sustansia aat. Ne’e molok legalizasaun, opera iha laran laran, aprende planta intimamente bainhira servisu iha mundu kannabis tradisional underground. Liuhusi tempu, nia transisaun husi avantura risku sira ne’e ba kria negósiu legal, legítimu bazeia iha integridade invez eksplorasaun.

Colin tuir mai sai inzheneiru software treinadu formalmente, halo dezenvolvimentu kostumi ba Baylor College of Medicine — husi instituisaun mediku prestijozu liu iha Texas Medical Center. Kombinasaun ne’e entre knar planta kannabis ne’ebé aprofundadu no presizaun téknika nivel mediku define tudo ne’ebé OilWell halo ohin loron.

Bentley: Kaman ne’ebé Hahú Tudo

Istória orijin OilWell laós kona-ba planu negósiu. Kona-ba kaman ida naran Bentley. Bentley laós de’it animal — nia familia, kompañia ne’ebé tuur Colin liuhusi tempu difísil liu. Bainhira Bentley moras aat, veterináriu sira hatete verdade ne’ebé ema nain animal la hakarak rona: eutanasia mak opsaun úniku umanu. Bentley paralizadu iha ain kotuk. Sira hateten medikasaun tansaun sei destroy órgaun internu, kansa sofre liu-tan. Hili ne’e mak deklínus todan ne’ebé tansaun ka mata mesaun merkía imediata.

Maibe taka tiha Bentley laós opsaun. Iha peskiza desesperadu ba alternativa, Colin topu CBD liuhusi pergunta ne’ebé troka tudo. Servisu-salva naran Jessica husu: “Ita hambara tonelada kannabis no ita seidauk rona kona-ba CBD?”

Colin iha esperiénsia kannabis — maibe rekreativu. Nia seidauk explora aplikasaun terapéutiku. Pergunta Jessica nian expón fatin beik ne’ebé sai misaun.

Colin aprende kria pasta douradu CBD. Ne’e laós kura, maibe bele salva moris. No esperansa ne’e entrega buat veterinária mediku hateten impossível: Bentley levanta. Nia lakon ba Colin no hatama bola. Husi paralizadu no enfrenta eutanasia to’o buska nia bola. Kaman sira la responde ba placebo. Ne’e medikamentu kannabinoid halo buat farmaséutiku labele halo.

Bentley moris tinan 10 tan, mate natar iha tinan 20. Durante tinan sira ne’e, Colin dezenvolvia fórmula espesializadu ba kada kondisaun relasiona ho idade:

• Neurodegenerasaun → Propiedade neprotektivu CBG no agonismu PPARγ THCa ba protesaun selula oin
• Dementia → Papel CBC iha neurogénesi
• Glaucoma → Agonismu CB1 THC ba reduksaun presaun intraokular
• Artrite todan → Abordaje anti-inflamasaun multi-linia uza CBD, CBG, THCa, no beta-cariofilenu servisu liuhusi sistema reseptor difirenti simultaneamente

Kannabinoid úniku la sufisiente. Kondisaun ne’ebé dezenvolve Bentley presiza sinergia multi-kannabinoid. CBD de’it labele atende tudo. Kannabinoid minor hanesan CBG, CBN, no CBC sai krusial. Presizaun farmaséutiku importante — moris Bentley depende ba akurásia fórmula, laós teb-teb.

Viagem Bentley nian sai entrada Colin nia iha kannabis liuhusi halo mabeus. Sia misaun atu kria solusaun real ne’ebé alivia tansaun no sofrimentu, laós de’it ba animal maibe ba ema. Istória Bentley mak fundasaun OilWell.

Colin nia Batalha Pessoal: PTSD no Husik Benzo

Colin mos hatene dependensia farmaséutiku pessoalmente. Nia luta ho PTSD no vistu benzodiazepina. Bainhira nia deside husik Xanax, nia halo direitamente — notoriously difísil no perigozu — uza knaar kannabinoid ne’ebé nia dezenvolve bainhira manten Bentley moris.

Fórmula Peace Gummies kria iha ezperimentu meia-noite bainhira luta liuhusi husik benzo. Atu garante aliviu lails, OilWell mos oferese fórmula Peace Gummies iha forma vape, ne’ebé Colin uza pessoalmente atu jere insonia no PTSD forte. Ne’e laós knaar teóriku. Colin moris buat ema pasiente RSO moris: desespera ba aliviu, farmaséutiku la servisu, descuberta katak kannabinoid sira servisu bainhira pilula labele.

Ita-nia Fórmula Uza liuhusi Doitor

Liuhusi tempu, benefísiu terapéutiku ne’ebé Colin descobre liuhusi Bentley sai ezenu OilWell. Ami dezenvolve fórmula doitor sira uza ba kondisaun hanesan doença Crohn, IBS, ulcerativa kólika, PTSD, vistu benzo, no insonia. Ita-nia fókus sempre atu halo kannabis akesivél no efetivu ba ema hotu, inklui veganu, diabetes, no ema ho presizaun saúde espesífiku.

Hétu Feature ABC13: Validasaun Independent

Entre Setembru 2019 no Abril 2023, ABC13 Houston feature OilWell Cannabis iha segmentu notísia distinctu hétu. Lima repórter b’esik husu ami liuhusi tinan sira. Operadór cannabis Houston seluk ruma aparese ho fokuensia ka luan ne’e.

Setembru 2019 — Boom negósiu CBD. Colin nia frase fundasaun: “Laós ha’u-nia planu atu vende azeita tahan. Laós ha’u-nia planu atu vende esperansa. Maibe iha peskiza sufisiente hodi ema presiza hatene no koko no iha versaun di’ak liu atu bazeia sira-nia opiniaun ba komprende se karik ne’e los ka sala ba sira.”

Marsu 2021 — Desriminalizasaun no empreendedorismu. Colin: “Tansaun mai liu husi forma barak.”

Maiu 2021 — Investigasaun Delta-8 THC. Onestidade ikóniku Colin nian: “Karak mabeus.”

Agustu 2021 — Distribuisaun vakina COVID. OilWell doneasaun 1,000 kavial pre-roll (aproximadamente $35,000 iha produtu) atu estimula vakina, koordena ho Sidade Houston.

Outubru 2021 — Proibisaun Delta-8. Colin proativamente hasai produtu Delta-8 hotu molok aplikasaun no hateten operadór seluk ne’ebé la hatene katak sira angra narkótiku Skeda I.

Outubru 2022 — Perdáun marijuana Biden. Colin revela nia istória kondensaun marijuana: “Ha’u gosta haree ema labele sofre tan husi ne’e.”

Abril 2023 — Espesial 4/20. Colin defini prezente hanesan “Renasensa” ba cannabis Texas.

Feature sira ne’e dokumenta padrão konsistente: bainhira ABC13 presiza esplika produtu cannabis, mudansa legal, ka inisiativa saúde komunitária, sira kontakta OilWell. Rekonitmentu ne’e labele sosa — de’it bele merese.

Filosofia RSO OilWell: Prinsípiu Esrúlu

1. Akesibilidade liu husi Gatekeeping

La presiza kartaun mediku. Ema idade 21+ bele sosa. Ami angra nasaun laran liu Estados Unidos no internasionál ba kliente ne’ebé verifika legalidade lokál — inklui ba Timor-Leste ne’ebé produtu deriva husi kanbáns permítidu. Rick Simpson fiar medikamentu tenke akesivél ba ema hotu; OilWell kria produtu no modelo distribuisaun ne’ebé halo ne’e akesivél legalmente.

2. Poténsia Pasiente Kontrola

THCa bele venda iha forma ázidu, la-psikoativa. Ita deside se karik uza raw ba benefísiu la-psikoativu ka dekarboksiliza ba poténsia psikoativu kompletu. Simpson fiar pasiente tenke kontrola sira-nia medikamentu rasik; ami inženha produtu ne’ebé tau kontrola ida iha ita-nia liman liuhusi kimia invez retórika.

Ba leitor Timor-Leste, ne’e signifika katak ita bele uza ita-nia azeita sublingual durante loron bainhira la tau efektu, depois dekarboksiliza parte ida iha kalan ba efektu forte liu. Ita kontrola experiénsia.

3. Fórmula Open-Source

Ami publika ita-nia fórmula kompletu publikamente — kada kannabinoid, kada miligrama, kada pursentu — atu ema ida ne’ebé labele pagar ita-nia produtu bele hetan ingrediente sira no kria sira-nia versaun. Simpson fo nia azeita grátis no tau oin ema oinsá halo; ami adapta ethos ne’e ba merkadu modernu liuhusi venda produtu manufatura profisionál no publika rezeta.

Ba komunitáriu ita-nia Timor-Leste ne’ebé disparidade ekonomia eziste, abordaje open-source ne’e responde direitamente ba akesibilidade. Fórmula kompletu RSO Sublingual Oil no Vape Cartridge aparese tuir mai iha gía ida-ne’e. Se ita bele hetan distiladu kannabinoid individual, ita bele replika rasik.

4. Evidensia-Informadu, La Evidensia-Sobe-Liu

Seksaun GENERAL KNOWLEDGE iha gía ida-ne’e reprezenta ita-nia kompromisu atu edukasaun loos kona-ba science ne’e de’it hateten. Simpson opera la iha asesu ba literatura revista kolega; ami iha asesu ne’e no uza atu distingue entre ne’ebé apoiu di’ak, ne’ebé emergente, no ne’ebé sobe liu.

Farm Bill Compliance no Eskema Legal THCa: Buat ne’ebé Leitor Timor-Leste Tenke Hatene

Farm Bill 2018 legaliza kanbáns no produtu deriva husi kanbáns ne’ebé kontén menus husi 0.3% delta-9 THC tuir pezu menu iha nivel federal iha Estados Unidos. Eskema legal ne’e mak fundasaun ita-nia desenhu produtu RSO.

Ita-nia RSO Sublingual Oil kontén de’it 90 miligrama delta-9 THC iha botella 30 mL — 3 miligrama mililitru — menus husi limitus 0.3%. Kannabinoid hotu deriva husi kanbáns. Produtu ne’e legal liuhusi lei federal U.S.

THCa mak kaun. THCa (tetrahidrokanabinoliku ázidu) mak ázidu, la-psikoativu, prekursor ba delta-9 THC. Iha ponto venda, THCA Farm Bill compliant tamba seidauk konvertidu ba delta-9 THC.

Signifikadu prátiku ba Timor-Leste: Ita bele legalmente sosa, possuí, no transporta ita-nia produtu ne’ebé kontén THCa. Desizaun atu ativa liuhusi kaler mai depos sosa, iha ita-nia fatin privadu. Ne’e signifika produtu mesma bele funsiona hanesan anti-inflamasaun la-psikoativu (uza raw) ka farmasia psikoativa poténsia kompletu (depois dekarboksilasaun) — tuir desizaun ita rasik.

Dekarboksilasaun: Konverti THCa ba THC

THCa konverti ba delta-9 THC bainhira kaler iha 260°F (125°C) iha loron 45-60 minutu iha fornu tahan vidru. Razaun konversaun: 1 mg THCa = 0.877 mg delta-9 THC depois dekarboksilasaun (reflete perda molekula CO₂).

Ita-nia azeita sublingual kontén 1,500 mg THCa. Bainhira dekarboksiladu kompletu, ne’e prodús aproximadamente 1,315 mg delta-9 THC. Hamutuk ho delta-9 THC 90 mg existente iha fórmula, ita hetan aproximadamente 1,405 mg delta-9 THC — fo ita poténsia psikoativa komparável ba RSO ilegal tradisional, legal kompletu.

Ba leitor Timor-Leste: Ita kontrola ativasaun. Uza raw ba aliviu funsional loron ida. Dekarboksiliza ba forsa terapéutiku kalan. Flexibilidade ne’e valoriza liu-tan ba ema ne’ebé servisu, ko’alia, ka presiza manten klaru-oin durante loron.

Notísia legal importante: THCa konverti ba delta-9 THC bainhira kaler. Kliente responsável atu komprende no konforme lei Timor-Leste kona-ba produtu kannabinoid. OilWell angra ho dokumentasaun kompletu, Sertifikadu Análise (COAs), no resibu. Kliente internasionál aséita risku aduaneiru no legal hotu.

Fórmula Open-Source: Transparénsia Kompletu

Fórmula RSO Sublingual Oil

Kannabinoid	Kantidade
CBD	4,500mg
CBG	3,000mg
Delta-8 THC	6,000mg
THCa	1,500mg
Delta-9 THC	90mg
CBN	750mg
CBC	750mg
Total Kannabinoids	16,590mg

• Terpenos Vivos: 5% (haree perfil terpeno iha kraik)
• Carrier: Azeita MCT orgániku
• Tamanhu Botella: 30mL
• Poténsia: 553mg kannabinoid ativu mililitru
• Presu: $129.99 USD

Fórmula RSO Vape Cartridge

Kannabinoid	Pursentu
CBD	30%
CBG	20%
Delta-8 THC	15%
THCA	10%
CBN	10%
CBC	10%

• Terpenos Vivos: 5%+
• Tamanhu Cartridge: 1 Grama
• 510-thread: Kompatibilidade bateria universal
• Presu: $49.99 USD

Perfil Terpeno (Produtu Rua)

• Limoneno — azedu-kidun, hadia humor
• Mirceno — todan-rai, relaxante
• Kariofilenu (β-caryophyllene) — pimenta/rsi, ativasaun reseptor CB2 ba inflamasaun
• Pineno — foun-foun floresta, hadia klaru-oin
• Linalool — flora/lavandula, kalma
• Humuleno — matenek, todan, anti-inflamasaun
• Terpinoleno — pinu, frutu, komplexu

Fórmula Open-Source Orijinál: Pasta Douradu CBD Bentley

Ami publika ne’e tinan barak molok ita-nia fórmula RSO — rezeta ne’ebé salva Bentley:

Ingrediente:

• 1/2 xícura pó kurkuma orgániku
• 1 xícura bee
• 1/3 xícura azeita kóku (la rafinádu, orgániku)
• 1-2 koher pimenta preta moú fresku (importante ba absorpsaun)
• Azeita CBD (dosi depende tamanhu/presizaun)

Instrusaun:

1. Hafour kurkuma no bee iha paneira, haruka liuhusi kalor menus to fórmula pasta todan (7-10 minutu)
2. Tau azeita kóku no pimenta preta, hafour di’ak
3. Penetra no armazena iha frigorífiku to loron 2
4. Hafour kantidade ki’ik ho komida animal 1-2 beses loron, hahu ho dosi CBD ki’ik

Ba nain animal iha Timor-Leste: Rezeta ne’e uza ingrediente sira disponível lokálmente ka liuhusi forneseur online. Ne’e demonstra ita-nia kompromisu ba akesibilidade — ami fo saida bele salva moris.

Siénsia Kannabinoid: Buat ne’ebé Leitor Timor-Leste Presiza Hatene

CBD: Kannabinoid Evidensia Hahú-liu

Evidensia apoiu di’ak: Transtornu konvulsivu (Epidiolex FDA aprova) [1][2]
Ansi: Meta-análise 2024 ho partisipante 316 hetan sinál ansiólítiku signifikante, maibe autor sira stress amostra kliniku limitadu [3]
Tansaun: Revisita 2022 hetan evidensia prometedor maibe heterogéneu; kualidade ensaíu limita konfiansa [4]
Dalan: Revisita 2022 hetan literatura metodolojikamente fraku [5]
Seguransa: Meta-análise 2022 hetan sinál elevasaun enzima fígadu; interasaun medikamentu importante [6]
Konkluzaun: Kannabinoid la-psikoativu forte liu, maibe evidensia konsentra iha indikasaun espesífiku, la reivindikasaun wellness luan

Ba komunitáriu Timor-Leste ne’ebé enfrente epilepsia (espesialmente iha labarik ne’ebé tratamentu tradisional limitadu), CBD reprezenta opsaun kannabinoid kredivel liu, maibe asesu ba Epidiolex espesifikamente bele difisíl internasionálmente.

CBG: Kannabinoid Minor Prometedor

Perfil evidensia: Maioria prekliniku no nivel revisita; evidensia humanu esparsu [7][8]
Farmakolojia: Interasaun CB1/CB2, adrenoreseptor alfa-2, sinál 5-HT1A [7]
Área peskiza: Transtornu neurologiku, doença intestino inflamasaun, atividade antibotiku — hipótese prinsipál, la terapia provadu [7][8]
Kuidadu: Fahe komersialmente bainhira baze evidénsia mantein ki’ik [7]
Konkluzaun: Alvo peskiza kredivel, maibe la valida klinikamente

Ba leitor Timor-Leste ne’ebé interesadu iha saúde intestinal (IBS, Crohn) ka neproteksaun, CBG prometedor maibe tenke haree hanesan ezperimental.

Delta-8 THC: Psikoativu Ne’ebé Mal Komprense

Farmakolojia: Agonista parsial CB1, menus potente liu delta-9 THC [9]
Evidensia: Domina liuhusi estudu animal, relatu uza, kuidadu saúde públiku [10]
Seguransa: Relatu konsekuénsia adversu; kuidadu regulamentu no kualidade [10]
Manufatura: Estabilidade boot liu halo interese komersial, maibe subprodutu produtu importante [11]
Konkluzaun: Atividade farmakológiku real, karakterizasaun seguransa humanu la kompletu

Leitor Timor-Leste tenke komprende: delta-8 THC psikoativu. Ne’e sei aperece iha teste dorga. Ne’e laós “THC-lite” iha termu legal ka farmakológiku.

THCa: Prekursor Ázidu

Ne’e buat: Prekursor la-psikoativu ba delta-9 THC [12]
Psikoatividade: THCA rasik la psikoativu, maibe konverti ba THC bainhira kaler [12]
Peskiza: Estudu in vitro no kaman hatudu possibilidade anti-inflamasaun, neprotektivu, antineplastiku — la ekivalente ho rezutadu humanu [12]
Konkluzaun: Prekursor relevante ne’ebé interpretasaun depende dalan no prosesamentu

Ba Timor-Leste: Ne’e ingrediente ne’ebé fo ita asesu legal no kontrola poténsia. Uza raw ba aliviu la-psikoativu loron ida. Kaler ba farmasia poténsia kompletu kalan.

Delta-9 THC: Psikoativu Peskiza-liu

Apoiu di’ak: Enju/vomita relasiona ho kimio, apeti HIV/AIDS, rezultadu baluun tansaun/MS [1]
Tansaun: Revisita 2022 hetan produtu THC-aas bele fo benefísiu tansaun janela kurtu maibe aumenta tonteira, sedasaun, enjoo, diskontinuasaun [13]
Farmakokinétika: Inhaladu onset segundo-minutu, pik 15-30 min, durasaun oras; oral onset la’o tuir, durasaun naruk [14]
Risku saúde mental: Revisita 2025 hetan asosiasaun konsistente ho psikose/esquizofrenia no transtornu uza kannabis iha konsentrasoún-aas [15]
Seguransa: Ansi/panik iha dosi aas, takiikardia, mudansa presaun rán, dependénsia, kuidadu gravidez, lesaun pulmón vape [1][14][15]
Konkluzaun: Relevansia terapéutiku legítimu maibe liabilidade intoxikasaun no psikiátriku klaran liu

Ba leitor Timor-Leste: Delta-9 THC mak kompostu ne’ebé kria “mabeus”. Ita-nia produtu kontén de’it 90mg total iha botella (3mg/mL) — menus liu dosi loron 600-900mg tradisional RSO. Ne’e reduz risku impair drástikamente bainhira preserva poténsial terapéutiku.

CBN: Kannabinoid Dalan Marketizadu

Marketizasaun vs. evidensia: Reputasaun muito liu dadus [16][17]
Peskiza dalaik: Revisita 2021 peskiza 99 abstratu estudu humanu, la hetan ensaíu kliniku uza medida dalaik validadu atu apoiu klamak dalaik forte [16]
Atualizasaun 2024: Peskiza dalaik cannabis seidauk husik uza mundu real; presiza ensaíu di’ak liu [17]
Kontekstu kimiku: THC degrada ba CBN iha kondisaun baluun [12]
Konkluzaun: Ezemplu klaran ne’ebé reputasaun kultural sobe liu evidensia klinika

Ba Timor-Leste: CBN inklui iha ita-nia fórmula 750mg tamba ne’e parte hipótese entourage, maibe ami la sobe liu-nia efektu dalaik. Peskiza seidauk dezenvolve.

CBC: Kannabinoid Minor Emerjente

Evidénsia: Pré-kliniku ka revisita baze [18][19]
Farmakolojia: Difirenti husi kannabinoid major; potensial antinociceptivu, antibotiku, anti-konvulsivu [18]
Servisu animal: Efektu anti-inflamasaun, redús hipermobilidade intestinal, analgesia kaman, possibilidade relevansia neurobiológiku [19]
Kuidadu: Produtu counter-sell ho evidensia kliniku efikasidade ka seguransa ki’ik [18]
Konkluzaun: Kannabinoid minor sientifikamente kredivel ne’ebé merese peskiza liu

Ba Timor-Leste: CBC kompleta ita-nia perfil kannabinoid hitu. Ne’e parte ita-nia kompromisu ba efektu entourage, bainhira evidensia humanu limitadu.

Siénsia Terpeno: Dimensaun Aromátiku

Kuantenamentu kritiku ba leitor Timor-Leste: Klamak terpeno presiza interpretasaun estriktu liu klamak kannabinoid. Barak evidensia mai husi kompostu isoladu, azeita esensial, tahan laós-cannabis, ka modelu prekliniku. Prueba robusta efektu entourage klinikamente signifikativu iha ema seidauk limitadu [20][29].

Limoneno

Perfil: Fókus revisita no prekliniku [20]-[22]
Atividade: Antioksidante, anti-inflamasaun, kardioprotetivu, gastruprotetivu, imunomodulatoriu — barak husi literatura laos-umanu [21]
Seguransa: Produtu oksidasaun ale’erjenu kontaktu [22]
Konkluzaun: Bioativu maibe klamak terapéutiku espesífiku cannabis tenke konservadivu

Iha klima tropical Timor-Leste, frutu sirus abundant. Hanoin limon liu husi frutu limasaun no laran kontén limoneno — konektu kompostu ne’e ho ita-nia experiénsia loron-boron.

Mirceno

Perfil: Soik prekliniku, evidensia umanu limitadu [20][23]
Peskiza: Propiedade ansiolítiku, antioksidante, anti-inflamasaun, analgésiku — maibe estudu umanu laiha [23]
Kuidadu: Klamak konsumidor kona-ba sedasaun no “kadeira-travada” sobe liu prova umanu atual [20][23]
Konkluzaun: Bioatividade plausible, maibe klamak espesífiku kompostu manten liu evidensia

Kariofilenu (β-caryophyllene)

Perfil: Terpeno mekanistikamente interesante liu — agonista seletivu CB2 [24]
Peskiza: Anti-inflamasaun, imunomodulatoriu, antioksidante, neprotektivu, gastruprotetivu — konfirmasaun umanu limitadu [24]
Konkluzaun: Kandidatu forte ba signifikansia sistema kannabinoid, maibe la prova klinikamente

Ba Timor-Leste: Pimenta preta, especiaria komum iha kuzina Timorense, kontén kariofilenu. Koneksaun familiar ne’e halo siénsia akesivél liu.

Pineno

Perfil: Prekliniku prometedor, konfirmasaun umanu fráku [20][25]
Saúde oin: Sinál antioksidante, anti-inflamasaun, neprotektivu justifika estudu futuru, maibe ensaíu kliniku desenha di’ak laiha [25]
Kuidadu: Klamak hadia memória no kontra-efektu kognitivu THC manten hipótese [20][25]
Konkluzaun: Merese atensaun sientifiku, maibe klamak kognisaun forte tenke aprezenta hanesan esploratória

Floresta Timor-Leste nia sira riku iha espésie pinu. Hanoin foun-foun husi pinu kontén pineno, konektu kompostu ne’e ho ita-nia ambiente natural.

Linalool

Perfil: Interese prekliniku substansial, konfirmasaun direitu kliniku limitadu [20][22][25][26]
Peskiza: Farmakolojia stress, humor, saúde-oin; mekanizmu anti-depressivu possível [25][26]
Seguransa: Hidroperoxido linalool oksidadu sai ale’erjenu [22]
Konkluzaun: Kredivel sientifikamente maibe evidensia atual suporta frase konservadivu

Lavandula, ne’ebé kontén linalool, uza iha rekursu tradisional Timorense ba kalma no dalaik — kria ponte kultural ba terpeno ne’e.

Humuleno

Perfil: Interesante translasaun, estádiu inísiu [20][27]
Peskiza: Revisita 2024 eskopo hetan efektu biológiku anti-inflamasaun, servisu kaman baluun hatudu propiedade kannabimimétiku [27]
Konkluzaun: Alvo peskiza interesante, besik husi estabelese klinikamente

Terpinoleno

Perfil: Karakterizasaun kliniku menus liu [20][28]
Peskiza: Revisita sistemátiku 2021 hetan efektu biológiku relatadu domina liuhusi estudu in silico, in vitro no animal [28]
Konkluzaun: Biologicamente interesante maibe besik husi subdezenvolvida klinikamente

Oinsá Ita-nia Fórmula Konektu ba Evidensia

Kada kannabinoid no terpeno iha ita-nia fórmula RSO iha perfil evidensia dokumentadu iha gía ida-ne’e. Ami anka ita-nia deserisaun produtu ba rezumu evidensia kompostu-indivídu. Ami la isenta ita rasik husi eskema evidensia mesma ne’ebé aplika ba área luan.

Bainhira ita-nia gía RSO halo klamak peskiza kona-ba kompostu individual, gía ne’e fornese avaliasaun fonte — sitasaun revista kolega mesma, avaliasaun nivel-evidensia mesma, eskema interpretasaun konservadivu mesma. Ita-nia posisaun, hanesan hateten iha 2019, mak katak ita merece versaun informasaun di’ak liu atu ita bele koko no deside se karik ne’e los ka sala ba ita.

Gía ne’e MANESE fundasaun peskiza.

Entrega no Akesibilidade ba Timor-Leste

Anga Internasionál

OilWell angra internasionál no entrega ba nasaun barak liu kontinente baluun. Eskema legal THCA halo ne’e possível: tamba ita-nia produtu kontén menus husi 0.3% delta-9 THC iha ponto venda, ne’e konforme definisaun produtu deriva husi kanbáns liuhusi Farm Bill 2018.

Ba kliente Timor-Leste:

• Pakote hotu inklui dokumentasaun kompletu, Sertifikadu Análise (COAs), no resibu ba aduaneiru
• Apliku taxa entrega mínimu; kustu liu sei kobran ba kliente
• Ita responsável ba verifika legalidade iha Timor-Leste no aséita risku aduaneiru no legal hotu
• Kontakta ami: (832) 416-2816 ka [email protected]
• Entrega tipiku: 7-21 loron servisu depende prosesamentu aduaneiru

Ne’e signifika saida ba Timor-Leste: Rick Simpson labele angra nia azeita ba rai ruma — ne’e Skeda I, ilegal atu prodús, possui, ka transporta. Pasiente kanser iha Dili, ema sofre tansaun kroniku iha Baucau, ka veteranu iha Suai agora bele potensiálmente akesu formula RSO multi-kannabinoid poténsia kliniku mesma ne’ebé residente Houston simu liuhusi entrega loron-idu. Ami kria produtu ne’ebé bele tama liuhusi fronteira legalmente — kompleta fatin ida husi visaun Rick Simpson ne’ebé proibisaun halo impossível.

Teknolojia PANDEM1C SEO

Ita-nia sistema proprietáriu ho 14 millaun lokasaun geopolítika distinctu no liu 300 modelo AI lidera vizibilidade organik ba peskiza liu kontinente nen, halo produtu OilWell descobrível ba pasiente internasionál ne’ebé peskiza RSO iha sira-nia lian rasik. Bainhira ema ida iha Timor-Leste peskiza “RSO ba tansaun kroniku” ka “azeita kannabis legal Timor-Leste”, ita-nia konteúdu bazeia evidensia aparese.

Kontekstu Uza Espesífiku Kondisaun ba Timor-Leste

Avisu importante: Kontextu sira ne’e informa liuhusi peskiza sitada iha gía ida-ne’e. Sira LA órden mediku, LA tratamentu aprova husi FDA, no LA substitui kuidadu mediku profisionál. Produtu sira ne’e seidauk avalia husi Food and Drug Administration no la intensaun diagnóstika, trata, kura, ka previne doença ruma. Konsulta provisor saúde kualifiku antes uza produtu kannabinoid, espesialmente se ita iha kondisaun medika, toma medikamentu, gravida ka amamenta, ka iha kuidadu saúde. La opera veíklu ka makinaria bainhira inflúensia liuhusi kannabinoid psikoativu.

Enjoo no Apoiu Apeti Relasiona ho Kimioterapia

• Pre-kimio: 0.5-1.0 mL sublingual ~1 hora molok tratamentu
• Enjoo akutu breakthrough: 2-3 puf vape ba aliviu imediato (onset 1-2 min)
• Pos-kimio: 0.5 mL sublingual kada 6 oras bainhira presiza
• Apoiu dalaik: 1.0-2.0 mL sublingual molok toba (entrega 25-50mg CBN)
• Evidensia: delta-8 antiemétiku [9], delta-9 enjoo/vomita [1][13], CBD tampão ansiolítiku [3]

Ba pasiente kanser Timor-Leste ne’ebé viaja ba Dili ka rai liur ba tratamentu, protokolu ne’e bele komplementa kuidadu konvensional. Diskuti sempre ho ita-nia ekipa onkolojia.

Tansaun Kroniku (Fibromialgia, Artrite, Neuropatia)

• Loron: 0.3-0.5 mL raw sublingual — anti-inflamasaun la impair psikoativu
• Kalan: 0.5-1.0 mL dekarboksiladu sublingual — kombina aliviu tansaun ho apoiu dalaik CBN
• Tansaun breakthrough: Vape bainhira presiza ba onset rapidu
• Evidensia: CBD tansaun [4], delta-9 tansaun [13], kariofilenu CB2 [24], THCa COX-2 [12]

Barak ema servisu agrikultura Timor-Leste no idozu sira sofre dor artikulasaun kroniku no kondisaun inflamasaun. Abordaje multi-linia ne’e ataka tansaun liuhusi mekanizmu baluun simultaneamente.

Apoiu Dalaik

• Molok toba: 1.0-2.0 mL sublingual
• Iha 2.0 mL: entrega 50mg CBN (dosi investigadu iha literatura dalaik 2024)
• Iha 1.0 mL: entrega 25mg CBN (as liu limitasaun asosiadu ho disturb dalaik redús)
• Evidensia: CBN dalaik [16][17], revisita dalaik cannabis [17]

Ba komunitáriu Timor-Leste ne’ebé transtornu dalaik komon liuhusi stress, servisu turnu, ka kondisaun saúde, ne’e fornese opsaun la-benzodiazepina.

Ansi no Stress

• Aliviu funsional loron: 0.3 mL raw sublingual — CBD no CBG ataka dalan ansi la impair
• Kalan: 1.0 mL sublingual — perfil kompletu inklui CBN ba arquitetura dalaik
• Evidensia: CBD ansi [3], farmakolojia CBG [7][8], entourage limoneno [20]

Tuir ita-nia istória konflitu no trauma, PTSD no ansi afeta barak. Ne’e oferese instrumentu ba jestaun la sedasaun farmaséutiku.

Prinsípiu Titrasaun Jeral: Hahu Ki’ik, Halai Laas

Hahu ho 0.25-0.5 mL sublingual no avalia efektu liuhusi 2-3 oras antes aumenta. Resposta individual varia tuir pezu korpús, metabolizmu, toleransia, medikamentu konkorrente, no fator seluk.

Seguransa, Kualidade, no Konformidade Legal

Teste Laboratoriu Parte-Terceiru

Seda makibári passa teste komprehensivu:

• Poténsia: Análise HPLC/UHPLC konfirma kada kannabinoid ba akurásia ±2%
• Metal puan: Teste ICP-MS ba arséniku, kadmiu, chumbo, merkúriu liuhusi limitus FDA
• Pestisida: Peskiza 400+ kompostu liuhusi LC-MS/MS no GC-MS/MS
• Solvente rezidual: Verifikasaun GC headspace husi limitus FDA Klasse 3 (<5,000 ppm)
• Mikrobia: Peskiza patojenu komprehensivu inklui E. coli, Salmonella, Aspergillus

Sertifikadu Análise (COAs) disponível iha ita-nia website no inklui ho angra internasionál ba Timor-Leste.

Presizaun Legal

• Oin-fulin: 21+ ba produtu RSO hotu
• Konteúdu THC: Produtu hotu kontén menus husi 0.3% delta-9 THC; Farm Bill compliant; kannabinoid deriva husi kanbáns
• Disclaimer FDA: Seidauk avalia husi FDA; la intensaun diagnóstika, trata, kura, ka previne doença ruma; konsulta provisor saúde antes uza; rezultadu individual varia
• Avisu seguransa: Posível kause sonolénsia ka impair; la opera veíklu ka makinaria; konsulta doitor se gravida ka amamenta; tau longe husi labarik
• Responsabilidade legal: Komprador responsável atu verifika lei Timor-Leste; OilWell la asumi responsabilidade legal ba ita-nia uza ka desizaun dekarboksilasaun; invalidu ne’ebé proibidu lei

Operasaun Negósiu

• Lokasaun: 810 Richmond Avenue, Houston, TX 77006 (vizinhança Montrose)
• Orasu: Segunda-Kinta 10AM-7PM, Sesta-Sábadu 10AM-10PM, Domingu 10AM-4PM
• Estabelése: 2019
• Rendimentu anuál: ~$1M
• Avaliasaun Google: Karik 5.0 estrela
• Lisensa: Texas DSHS lisensa
• Kontaktu: (832) 416-2816, [email protected]
• Website: https://oilwellcbd.com/

Arte, fórmula, no embalaje hotu kria iha Houston uza de’it ita-nia rezeta rasik no ideia rasik.

Komparasaun Konkurente: Tansaun OilWell ba Timor-Leste

vs. RSO Ilegal Tradisional

Dimensaun	RSO Tradisional	RSO OilWell
Kannabinoid	THC de’it, variadivél	7 kannabinoid definidu ho rasun espesífiku
Padronizasaun	La iha	Teste-lab ba akurásia ±2%
Solvente	Naphtha/isopropil (toksiku)	La-solvente, azeita MCT alimentu-grau
Terpeno	Destrúi	Terpeno vivo 5% ho perfil definidu
Teste	La iha	COA panel kompletu
Preservasaun THCa	Lao	Sin, 1,500mg hanesan ingrediente separadu
Dominasaun delta-9 THC	60-90%	De’it 90mg total iha botella
Status legal	Ilegal	Farm Bill compliant
Aksesu iha Timor-Leste	Labele angra	Anga internasionál disponível
Kontrola pasiente	La iha	Ita kontrola dekarboksilasaun
Kustu	Presu merkadu-hatan	$129.99 ho alternativa open-source

vs. Cannabis Mediku Texas (TCUP)

TCUP presiza kartaun mediku ho kondisaun kualifiku (kanser, PTSD, epilepsia, autizmu, doença terminal, ALS, MS, transtornu konvulsivu, doença neudegenerativa inkuravel). Menu husi 10,000 Texas aktivamente uza.

OilWell presiza de’it oin 21+. La kartaun mediku. La kondisaun kualifiku. Ami angra direitamente ba Timor-Leste. Produtu mesak. Aksesu legal.

vs. Produtu CBD-de’it Hemp

RSO CBD tipiku kontén ~1,000mg total kannabinoid, soinu CBD. OilWell entrega 16,590mg total liuhusi tujuh kannabinoid. Se karik ita buka liuhusi CBD molécula úniku, abordaje multi-kannabinoid ita-nia oferese poténsial terapéutiku luan liu signifikante.

Misaun OilWell: Liu Husi Produtu

OilWell Cannabis liu husi brande — mak promesa ba ita-nia kliente iha Timor-Leste no mundu tomak katak ami sempre esforsu atu entrega produtu kannabis di’ak liu, hahú-liu, disponivel. Ami la hodi tuir tendénsia. Ami hodi establese sira.

Bainhira ita kontinua kresimentu, ita-nia fokus mantein nivel integridade, kreatividade, no kompromisu mesma ne’ebé define ita hosi loron Bentley levanta, lakon sai, no hatama bola atu joga.

Ita-nia misaun simples: kria produtu ho intensaun, responde direitu, no nunka finji katak kannabis los ba ema hotu. Ba ita-nia komunitáriu Timor-Leste, ne’e signifika edukasaun loos kona-ba buat ne’ebé servisu, la servisu, no possivelmente servisu ba ita. Signifika aksesu legal ba formula multi-kannabinoid ne’ebé respeita siénsia no sávia tradisional planta. Signifika kontrola pasiente ba ita-nia medikamentu rasik. Signifika rezeta ne’e livre se ita presiza.

Husi Houston to’o Dili, husi Texas Medical Center to’o postu saúde komunitáriu Timor-Leste, husi kaman paralizadu naran Bentley to’o ema hotu buka aliviu — ne’e mak OilWell Cannabis.

ENGLISH

Rick Simpson Oil (RSO) in Timor-Leste: The Complete Guide by OilWell Cannabis

Understanding Rick Simpson Oil: Where It All Began

Who Was Rick Simpson?

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada — not a doctor or scientist, but a power engineer and maintenance worker who became the world’s most famous cannabis oil advocate through personal hardship. In 1997, while working at a hospital in Moncton, Simpson fell from scaffolding and suffered a serious head injury that left him with persistent tinnitus, dizziness, and post-concussion symptoms. The medications his doctors prescribed either failed to help or made his condition worse. When he asked his physician about cannabis, the request was refused.

This experience of medical system failure resonates deeply here in Timor-Leste, where many families still face long journeys to reach specialist care in Dili or must cross borders to Indonesia for treatment. When conventional medicine falls short — whether for chronic pain, cancer support, or trauma-related conditions — people throughout our island nation begin searching for alternatives. That search is what led Rick Simpson down a path that would eventually reach even our remote communities in Oceania.

The 1974 Study That Sparked Everything

Simpson’s interest in concentrated cannabis oil deepened after learning about a 1974 study funded by the National Institutes of Health and conducted at the Medical College of Virginia, where THC was reported to slow or shrink tumors in mice. The study was originally intended to demonstrate harm, but its findings became a foundational reference point for Simpson’s later advocacy. It is crucial for our Timor-Leste readers to understand: these findings were never replicated in controlled human cancer trials. The gap between what happened in laboratory mice and what happens in human patients is vast — a distinction we must honor with complete honesty.

The 2003 Skin Cancer Story That Created RSO

The pivotal moment came in 2003 when Simpson noticed three bumps on his arm. His doctor diagnosed them as basal cell carcinoma. Rather than pursuing conventional treatment, Simpson applied concentrated cannabis oil directly to the lesions, covered them with bandages, and claimed they disappeared within four days. No independent medical verification of this outcome was ever published. No biopsy confirmation exists in any peer-reviewed source. No clinical follow-up documentation has ever emerged.

This is the heart of the RSO origin story — and the place where honesty matters most. Here in Timor-Leste, where community health workers and traditional healers are often the first line of care, we understand the power of personal testimony. Stories spread through families and villages. When someone we trust says something worked for them, we listen. That cultural wisdom is valuable, but it is not the same as medical evidence. Simpson’s account is historically significant as the catalyst for a global movement. It is not, and cannot be, considered clinical proof.

The Crusade — Spreading the Oil

After his 2003 experience, Simpson committed himself to producing and distributing concentrated cannabis oil from his property in Maccan, Nova Scotia. He gave it away for free to cancer patients and others in his community. He charged nothing. By his own account, he helped people with cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and multiple sclerosis. He grew his own cannabis or sourced it from trusted growers. There was no strain standardization. No lab testing. No quality control. Every batch was different because the process was crude and variable.

This free-distribution model resonates with Timor-Leste’s communal values — our fo’er system of mutual support, our tradition of sharing resources during ceremonies and crises. But Simpson’s approach also had real limitations that matter for our community’s health and safety.

The Documentary That Made RSO Global

Simpson’s story reached worldwide audiences through the 2005 documentary Run From The Cure, directed by Christian Laurette. The film was distributed freely online and became foundational in cannabis communities. For many people, Run From The Cure was their first introduction to concentrated cannabis oil as medicine. In Timor-Leste, where internet access has grown dramatically in recent years, this documentary has likely reached even our most remote districts through mobile phones and shared videos. It created a global vocabulary for RSO that transcends borders.

Legal Conflict and Exile

Simpson’s advocacy brought him into direct conflict with Canadian law. The Royal Canadian Mounted Police raided his property in 2005 and again in 2009. He was charged with cannabis cultivation, possession, and trafficking. Facing continued legal pressure, Simpson eventually left Canada and relocated to Europe, living in Croatia and later the Netherlands, where he continued his advocacy from abroad.

This history of criminalization is not abstract for Timor-Leste. During our own 24-year struggle for independence, many of our people faced persecution for traditional practices outside colonial law. The experience of being punished for using a plant that others consider medicine is something our older generation understands intimately. It makes the legal framework we operate under today — the 2018 U.S. Farm Bill that legalizes hemp-derived cannabinoids containing less than 0.3% delta-9 THC — all the more important. OilWell operates legally under this framework, which means we can ship to Timor-Leste where local laws permit hemp-derived products.

The Traditional RSO Protocol: 60 Grams Over 90 Days

Simpson’s core treatment recommendation was consuming 60 grams of oil over approximately 90 days. The titration schedule began with a dose the size of half a grain of rice (10-15mg) taken three times daily, doubling every four days until reaching approximately 1 gram per day by weeks 5-12. At peak dosing, patients were consuming roughly 600-900mg of delta-9 THC daily — doses far exceeding anything studied in controlled clinical settings.

Critical context for Timor-Leste readers: This protocol has no controlled trial validation. The oil Simpson used was crude, unstandardized, and variable. Consuming 600-900mg of THC daily carries serious risks including severe intoxication, anxiety, panic, tachycardia, hypotension, and cannabis use disorder. These risks are well-documented in peer-reviewed literature. For patients with active cancer who are medically complex, using unregulated, unstandardized cannabis oil as a primary treatment — potentially in place of proven therapies — introduces harm that extends beyond the oil itself.

What Traditional RSO Actually Was

Traditional RSO was defined by Simpson’s method, not by lab specifications:

Source material: Single high-THC indica strain, no standardization
Extraction solvent: Naphtha (petroleum-based) or 99% isopropyl alcohol — neither food-grade
Appearance: Nearly black, thick, tar-like oil with possible solvent-residual smell
Cannabinoid profile: THC-dominant (60-90% estimated), fully decarboxylated, unmeasured
Terpene content: Minimal to none — destroyed by heat and solvent process
Standardization: None — every batch different
Testing: No COA, no quantification, no contaminant screening
Residual solvent risk: Significant — naphtha may contain benzene, toluene, and other carcinogens

Simpson’s Claims vs. The Evidence Record

What Simpson claimed: RSO could cure cancer and many other diseases. He encouraged patients to use it instead of proven cancer therapies.

What the preclinical literature shows: In vitro studies demonstrate THC and CBD can induce apoptosis and inhibit proliferation in certain cancer cell lines. Animal models show some tumor-growth inhibition. These findings are scientifically interesting but have not translated into proven human cancer cures.

What the preclinical literature does NOT show: No human clinical trial has demonstrated that RSO or any cannabis oil preparation cures cancer. The gap between laboratory results and human outcomes is vast.

Institutional positions:

• U.S. National Cancer Institute acknowledges laboratory studies but does not endorse cannabis as cancer treatment
• FDA has not approved any cannabis plant product for cancer treatment
• Health Canada has never approved RSO for cancer
• NCCIH identifies strongest evidence for rare epilepsies, chemo nausea, and HIV/AIDS appetite

What Simpson got right: He drew attention to cannabinoids as serious biomedical research when the world was ignoring them. He helped create conditions for legal cannabis industry. The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What he overstated: His cure claims exceeded the evidence. Encouraging patients to use RSO instead of proven cancer therapies carries genuine harm potential. Delayed treatment is a documented concern.

The OilWell Story: From Border Town to Global Access

Our Founder: Colin Valencia

OilWell Cannabis was founded by Colin Valencia in Houston, Texas — but our roots trace back to McAllen, Texas, right across the river from Reynosa, Tamaulipas, Mexico. The McAllen-Reynosa area, known as the Borderplex, is one of the most economically challenged and dangerous regions along the U.S.-Mexico border. Colin grew up witnessing violence, seeing best friends killed or imprisoned, and learning to navigate a world where survival required both hustle and wisdom.

By sixteen, Colin had to leave home. He could have taken darker paths — many did. Instead, he focused on cannabis, seeing it as a safer alternative to harder substances. This was long before legalization, operating in the shadows, learning the plant intimately while working in the traditional cannabis underground. Over time, he transitioned from those risky ventures to creating a legal, legitimate business built on integrity rather than exploitation.

Colin later became a formally trained software engineer, doing custom development work for Baylor College of Medicine — one of the most prestigious medical institutions in the Texas Medical Center. That combination of deep cannabis plant knowledge plus medical-grade technical precision defines everything OilWell does today.

Bentley: The Dog Who Started Everything

OilWell’s origin story isn’t about a business plan. It’s about a dog named Bentley. Bentley was more than a pet — he was family, a companion who stood by Colin through the toughest times. When Bentley fell seriously ill, veterinarians delivered the verdict no pet owner wants to hear: euthanasia was the only humane option. Bentley was paralyzed in his back legs. They said pain medications would destroy his internal organs, causing more suffering. The choice was painful prolonged decline or immediate mercy killing.

But giving up on Bentley was not an option. In a desperate search for alternatives, Colin stumbled upon CBD through a question that changed everything. A rescue worker named Jessica asked: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

Colin had cannabis experience — but it was recreational. He had never explored therapeutic applications. Jessica’s question exposed a blind spot that became a mission.

Colin learned to create CBD golden paste. It wasn’t a cure, but it was a lifeline. And that hope delivered what veterinary medicine said was impossible: Bentley got up. He walked over to Colin and brought him his ball. From paralyzed and facing euthanasia to fetching his ball. Dogs don’t respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, dying naturally at age twenty. During those years, Colin developed specialized formulas for every age-related condition:

• Neurodegeneration → CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection
• Dementia → CBC’s role in neurogenesis
• Glaucoma → THC’s CB1 agonism for intraocular pressure reduction
• Crippling arthritis → Multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene working through different receptor systems simultaneously

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. CBD alone couldn’t address everything. Minor cannabinoids like CBG, CBN, and CBC became critical. Pharmaceutical precision mattered — Bentley’s life depended on formula accuracy, not guesswork.

Bentley’s journey was Colin’s entry into cannabis beyond getting high. It became a mission to create real solutions that alleviate pain and suffering, not just for pets but for people. Bentley’s story is OilWell’s foundation.

Colin’s Personal Battle: PTSD and Benzo Withdrawal

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey — notoriously difficult and dangerous — using the cannabinoid knowledge he developed keeping Bentley alive.

The Peace Gummies formula was created during midnight experiments while fighting through benzo withdrawal. To ensure quick relief, OilWell also offers the Peace Gummies formula in vape form, which Colin personally uses to manage his insomnia and severe PTSD. This is not theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

Our Formulas Used by Doctors

Over time, the therapeutic benefits that Colin discovered through Bentley became the core of OilWell’s work. We have developed formulas that doctors use for conditions like Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. Our focus has always been making cannabis accessible and effective for everyone, including vegans, diabetics, and those with specific health needs.

Seven ABC13 Features: Independent Validation

Between September 2019 and April 2023, ABC13 Houston featured OilWell Cannabis in seven distinct news segments. Five different reporters sought us out across those years. No other Houston cannabis operator appears with that frequency or breadth.

September 2019 — CBD business boom. Colin’s foundational quote: “I’m not trying to sell people snake oil. I’m not trying to sell people hope. But there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

March 2021 — Decriminalization and entrepreneurship. Colin: “Pain comes in a lot of different forms.”

May 2021 — Delta-8 THC investigation. Colin’s iconic honesty: “Maybe you want to get high.”

August 2021 — COVID vaccine giveaway. OilWell donated 1,000 caviar pre-rolls (approximately $35,000 in product) to encourage vaccination, coordinating with the City of Houston.

October 2021 — Delta-8 ban. Colin proactively removed all Delta-8 products before enforcement and warned other operators who were unknowingly shipping Schedule I narcotics.

October 2022 — Biden marijuana pardon. Colin revealed his personal marijuana conviction history: “I would love to see people not get hurt for this anymore.”

April 2023 — 4/20 special. Colin framed the present as a “Renaissance” for Texas cannabis.

These features document a consistent pattern: when ABC13 needed to explain cannabis products, legal changes, or community health initiatives, they called OilWell. This recognition cannot be purchased — it can only be earned.

The OilWell RSO Philosophy: Four Core Principles

1. Accessibility Over Gatekeeping

No medical card is required. Anyone age 21 or older can purchase. We ship nationwide across the United States and internationally to customers who verify local legality — including to Timor-Leste where hemp-derived products are permitted. Rick Simpson believed medicine should be accessible to everyone; OilWell built a product and distribution model that makes that accessible legally.

2. Patient-Controlled Potency

THCa is sold in its acidic, non-psychoactive form. You decide whether to use it raw for non-psychoactive benefits or to decarboxylate it into delta-9 THC for full psychoactive potency. Simpson believed patients should control their own medicine; we engineered a product that puts that control in your hands through chemistry rather than rhetoric.

For Timor-Leste readers, this means you can use our sublingual oil during the day without impairment, then decarboxylate a portion at night for stronger effects. You control the experience.

3. Open-Source Formulas

We publish our complete formulas publicly — every cannabinoid, every milligram, every percentage — so that anyone who cannot afford our products can source ingredients and make their own version. Simpson gave his oil away for free and taught people how to make it; we adapted that ethos for the modern marketplace by selling a professionally manufactured product and publishing the recipe.

For our Timor-Leste community where economic disparities exist, this open-source approach directly addresses accessibility. The full RSO Sublingual Oil formula and Vape Cartridge formula appear later in this guide. If you can source the individual cannabinoid distillates, you can replicate it yourself.

4. Evidence-Informed, Not Evidence-Overstating

The GENERAL KNOWLEDGE section in this guide represents our commitment to honest education about what the science actually says. Simpson operated without access to peer-reviewed literature; we have that access and use it to distinguish between what is well-supported, what is emerging, and what is overstated.

Farm Bill Compliance and the THCa Legal Framework: What Timor-Leste Readers Must Know

The 2018 Farm Bill legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level in the United States. This legal framework is the foundation of our RSO product design.

Our RSO Sublingual Oil contains only 90 milligrams of delta-9 THC in the entire 30 mL bottle — 3 milligrams per milliliter — well under the 0.3% threshold. All cannabinoids are hemp-derived. The product is legal under U.S. federal law.

THCa is the key. THCa (tetrahydrocannabinolic acid) is the acidic, non-psychoactive precursor to delta-9 THC. At the point of sale, THCa is Farm Bill compliant because it has not been converted to delta-9 THC.

The practical significance for Timor-Leste: You can legally purchase, possess, and transport our THCa-containing products. The decision to activate them through heating occurs after purchase, in your private setting. This means the same product can function as non-psychoactive anti-inflammatory (used raw) or as full-potency psychoactive medicine (after decarboxylation) — entirely at your discretion.

Decarboxylation: Converting THCa to THC

THCa converts to delta-9 THC when heated at 260°F (125°C) for 45-60 minutes in an oven-safe glass container. The conversion ratio: 1 mg THCa = 0.877 mg delta-9 THC after decarboxylation (reflecting loss of a CO₂ molecule).

Our sublingual oil contains 1,500 mg THCa. When fully decarboxylated, this yields approximately 1,315 mg delta-9 THC. Combined with the existing 90 mg delta-9 THC in the formula, you get approximately 1,405 mg total delta-9 THC — giving you psychoactive potency comparable to traditional illegal RSO, entirely legally.

For Timor-Leste readers: You control the activation. Use raw for daytime functional relief. Decarb for nighttime therapeutic strength. This flexibility is particularly valuable for those who work, drive, or need to remain clear-headed during the day.

Important legal notice: THCa converts to delta-9 THC when heated. Customers are responsible for understanding and complying with Timor-Leste laws regarding cannabinoid products. OilWell ships with full documentation, Certificates of Analysis (COAs), and receipts. International customers accept all customs and legal responsibility.

Open-Source Formulas: Complete Transparency

RSO Sublingual Oil Formula

Cannabinoid	Amount
CBD	4,500mg
CBG	3,000mg
Delta-8 THC	6,000mg
THCa	1,500mg
Delta-9 THC	90mg
CBN	750mg
CBC	750mg
Total Cannabinoids	16,590mg

• Live Terpenes: 5% (see terpene profile below)
• Carrier: Organic MCT oil
• Bottle Size: 30mL
• Potency: 553mg active cannabinoids per mL
• Price: $129.99 USD

RSO Vape Cartridge Formula

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Cartridge Size: 1 Gram
• 510-thread: Universal battery compatibility
• Price: $49.99 USD

Terpene Profile (Both Products)

• Limonene — citrus-bright, mood-enhancing
• Myrcene — earthy, relaxing
• Caryophyllene (β-caryophyllene) — pepper/spice, CB2 receptor activation for inflammation
• Pinene — forest-fresh, clarity-enhancing
• Linalool — floral/lavender, calming
• Humulene — woody, earthy, anti-inflammatory
• Terpinolene — piney, fruity, complex

The Original Open-Source Formula: Bentley’s CBD Golden Paste

We published this years before our RSO formulas — the recipe that saved Bentley:

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1-2 teaspoons freshly ground black pepper (important for absorption)
• CBD oil (dosage depends on size/needs)

Instructions:

1. Mix turmeric and water in saucepan, stir over low heat until thick paste forms (7-10 minutes)
2. Add coconut oil and black pepper, mix thoroughly
3. Cool and store in refrigerator for up to 2 weeks
4. Mix a small amount with pet’s food 1-2x daily, starting with low CBD dose

For Timor-Leste pet owners: This recipe uses ingredients available locally or through online suppliers. It demonstrates our commitment to accessibility — we give away what can save lives.

Cannabinoid Science: What Timor-Leste Readers Need to Know

CBD: The Most Evidence-Developed Cannabinoid

Best supported evidence: Seizure disorders (Epidiolex FDA-approved) [1][2]
Anxiety: 2024 meta-analysis of 316 participants found significant anxiolytic signal, but authors stress limited clinical sample [3]
Pain: 2024 review found promising but heterogeneous evidence; trial quality limits confidence [4]
Sleep: 2023 review found literature methodologically weak [5]
Safety: 2023 meta-analysis found liver enzyme elevation signal; drug interactions important [6]
Bottom line: Strongest non-psychoactive cannabinoid, but evidence concentrated in specific indications, not broad wellness claims

For Timor-Leste’s communities dealing with epilepsy (particularly in children where traditional treatments may be limited), CBD represents the most credible cannabinoid option, though access to Epidiolex specifically may be challenging internationally.

CBG: The Promising Minor Cannabinoid

Evidence profile: Mostly preclinical and review-level; human evidence sparse [7][8]
Pharmacology: CB1/CB2 interactions, alpha-2 adrenoceptors, 5-HT1A signaling [7]
Research areas: Neurologic disorders, inflammatory bowel disease, antibacterial activity — primarily hypotheses, not proven therapies [7][8]
Caution: Being sold commercially while evidence base remains thin [7]
Bottom line: Credible research target, but not clinically validated

For Timor-Leste readers interested in gut health (IBS, Crohn’s) or neuroprotection, CBG is promising but should be approached as experimental.

Delta-8 THC: The Misunderstood Psychoactive

Pharmacology: Partial CB1 agonist, less potent than delta-9 THC [9]
Evidence: Dominated by animal studies, use reports, public health concerns [10]
Safety: Reports of adverse consequences; regulatory and quality concerns [10]
Manufacturing: Greater stability drives commercial interest, but product byproducts matter [11]
Bottom line: Real pharmacologic activity, incomplete human safety characterization

Timor-Leste readers should understand: delta-8 THC is psychoactive. It will show on drug tests. It is not “THC-lite” in legal or pharmacologic terms.

THCa: The Acidic Precursor

What it is: Non-psychoactive precursor to delta-9 THC [12]
Psychoactivity: THCa itself is not psychoactive, but converts to THC when heated [12]
Research: In vitro and rodent studies suggest anti-inflammatory, neuroprotective, antineoplastic possibilities — not equivalent to human outcomes [12]
Bottom line: Relevant precursor whose interpretation depends on route and processing

For Timor-Leste: This is the ingredient that gives you legal access and potency control. Use it raw for non-psychoactive daytime relief. Heat it for full-strength nighttime medicine.

Delta-9 THC: The Most Studied Psychoactive

Best supported: Chemo-related nausea/vomiting, HIV/AIDS appetite, some MS/pain outcomes [1]
Pain: 2022 review found high-THC products may provide short-term pain benefit but increase dizziness, sedation, nausea, discontinuation [13]
Pharmacokinetics: Inhaled onset seconds-minutes, peaks 15-30 min, lasts hours; oral onset later, duration longer [14]
Mental health risk: 2025 review found consistent associations with psychosis/schizophrenia and cannabis use disorder at high concentrations [15]
Safety: Anxiety/panic at high doses, tachycardia, blood pressure changes, dependency, pregnancy concerns, vape lung injury [1][14][15]
Bottom line: Legitimate therapeutic relevance but clearest intoxication and psychiatric liabilities

For Timor-Leste readers: Delta-9 THC is the compound that creates the “high.” Our products contain only 90mg total in the bottle (3mg/mL) — well below traditional RSO’s 600-900mg per day. This dramatically reduces impairment risk while preserving therapeutic potential.

CBN: The Overmarketed Sleep Cannabinoid

Marketing vs. evidence: Reputation far ahead of data [16][17]
Sleep research: 2021 review screened 99 human-study abstracts, found no clinical trials using validated sleep measures to support strong sleep claims [16]
2024 update: Cannabis sleep research still doesn’t match real-world use; better trials needed [17]
Chemical context: THC degrades toward CBN under certain conditions [12]
Bottom line: Clearest example where cultural reputation exceeds clinical evidence

For Timor-Leste: CBN is included in our formula at 750mg because it’s part of the entourage hypothesis, but we don’t overstate its sleep effects. The research is still developing.

CBC: The Emerging Minor Cannabinoid

Evidence: Overwhelmingly preclinical or review-based [18][19]
Pharmacology: Distinct from major cannabinoids; antinociceptive, antibacterial, anti-seizure potential [18]
Animal work: Anti-inflammatory effects, reduced gut hypermobility, rodent analgesia, possible neurobiological relevance [19]
Caution: Over-the-counter products being sold with little clinical efficacy or safety evidence [18]
Bottom line: Scientifically credible minor cannabinoid deserving more research

For Timor-Leste: CBC completes our seven-cannabinoid profile. It’s part of our commitment to the entourage effect, even while human evidence remains limited.

Terpene Science: The Aromatic Dimension

Critical framing for Timor-Leste readers: Terpene claims need stricter interpretation than cannabinoid claims. Much evidence comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models. Robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Limonene

Profile: Review and preclinical focus [20]-[22]
Activity: Antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory — mostly from nonhuman literature [21]
Safety: Oxidation products are contact allergens [22]
Bottom line: Biologically active but cannabis-specific therapeutic claims should stay conservative

In Timor-Leste’s tropical climate, citrus fruits are abundant. The familiar scent of lemon and orange peel contains limonene — connecting this compound to your daily experience.

Myrcene

Profile: Mostly preclinical, limited human evidence [20][23]
Research: Anxiolytic, antioxidant, anti-inflammatory, analgesic properties — but human studies lacking [23]
Caution: Consumer claims about sedation and “couch-lock” exceed current human proof [20][23]
Bottom line: Plausible bioactivity, but compound-specific clinical claims remain ahead of evidence

Caryophyllene (β-caryophyllene)

Profile: Most mechanistically interesting terpene — selective CB2 receptor agonist [24]
Research: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective — human confirmation limited [24]
Bottom line: Strongest candidate for cannabinoid-system significance, but not clinically proven

For Timor-Leste: Black pepper, a common spice in Timorese cuisine, contains caryophyllene. This familiar connection makes the science more accessible.

Pinene

Profile: Promising preclinical, weak human confirmation [20][25]
Brain health: Antioxidant, anti-inflammatory, neuroprotective signals justify future study, but well-designed clinical trials lacking [25]
Caution: Claims about memory improvement and counteracting THC cognitive effects remain hypotheses [20][25]
Bottom line: Deserves scientific attention, but strong cognition claims should be presented as exploratory

Timor-Leste’s forests are rich in pine species. The fresh scent of pine needles contains pinene, connecting this terpene to our natural environment.

Linalool

Profile: Substantial preclinical interest, limited direct clinical confirmation [20][22][25][26]
Research: Stress, mood, brain-health pharmacology; possible antidepressant mechanisms [25][26]
Safety: Oxidized linalool hydroperoxides are recognized allergens [22]
Bottom line: Scientifically credible but current evidence supports cautious phrasing

Lavender, which contains linalool, is used in traditional Timorese remedies for calming and sleep — creating a cultural bridge to this terpene.

Humulene

Profile: Translationally interesting, early stage [20][27]
Research: 2024 scoping review found anti-inflammatory biologic effects, some rodent work suggesting cannabimimetic properties [27]
Bottom line: Interesting research target, far from clinically settled

Terpinolene

Profile: Least clinically characterized [20][28]
Research: 2021 systematic review found reported biological effects dominated by in silico, in vitro, and animal studies [28]
Bottom line: Biologically interesting but especially underdeveloped clinically

How Our Formulas Connect to the Evidence

Every cannabinoid and terpene in our RSO formula has its evidence profile documented in this guide. We anchor our product description to per-compound evidence summaries. We do not exempt ourselves from the same evidence standards applied to the broader field.

When our RSO guide makes research claims about individual compounds, this guide provides the source evaluation — the same peer-reviewed citations, the same evidence-tier assessments, the same cautious interpretation framework. Our position, as stated in 2019, is that you deserve the best possible version of information so you can give it a fair shot and decide whether it’s right or wrong for you.

This guide IS that research foundation.

Delivery and Accessibility to Timor-Leste

International Shipping

OilWell ships internationally and has delivered to multiple countries across multiple continents. The THCa legal framework makes this possible: because our product contains less than 0.3% delta-9 THC at point of sale, it meets the definition of a hemp-derived product under the 2018 Farm Bill.

For Timor-Leste customers:

• All packages include full documentation, Certificates of Analysis (COAs), and receipts for customs
• Minimum flat-fee shipping applies; excessive costs are billed to customer
• You are responsible for verifying legality in Timor-Leste and accept all customs and legal risk
• Contact us: (832) 416-2816 or [email protected]
• Typical delivery: 7-21 business days depending on customs processing

What this means for Timor-Leste: Rick Simpson could not ship his oil anywhere — it was Schedule I, illegal to produce, possess, or transport. A cancer patient in Dili, a chronic pain sufferer in Baucau, or a veteran in Suai can now potentially access the same clinical-strength multi-cannabinoid RSO formula that Houston residents receive via same-day delivery. We built a product that can move across borders legally — completing a piece of Rick Simpson’s vision that prohibition made impossible.

PANDEM1C SEO Technology

Our proprietary system with 14 million distinct geopolitical locations and over 300 AI models drives organic search visibility across six continents, making OilWell products discoverable to international patients searching for RSO in their own language. When someone in Timor-Leste searches “RSO for chronic pain” or “legal cannabis oil Timor-Leste,” our evidence-based content appears.

Condition-Specific Usage Context for Timor-Leste

Important disclaimer: These contexts are informed by research cited in this guide. They are NOT medical prescriptions, NOT FDA-approved treatments, and NOT substitutes for professional medical care. These products have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, take medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-Related Nausea and Appetite Support

• Pre-chemo: 0.5-1.0 mL sublingual ~1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 min onset)
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0 mL sublingual before bed (delivers 25-50mg CBN)
• Evidence: delta-8 antiemetic [9], delta-9 nausea/vomiting [1][13], CBD anxiolytic buffer [3]

For Timor-Leste cancer patients traveling to Dili or overseas for treatment, this protocol can complement conventional care. Always discuss with your oncology team.

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

• Daytime: 0.3-0.5 mL raw sublingual — anti-inflammatory without psychoactive impairment
• Nighttime: 0.5-1.0 mL decarboxylated sublingual — combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset
• Evidence: CBD pain [4], delta-9 pain [13], caryophyllene CB2 [24], THCa COX-2 [12]

Many Timor-Leste agricultural workers and older adults suffer from chronic joint pain and inflammatory conditions. This multi-pathway approach addresses pain through several mechanisms simultaneously.

Sleep Support

• Before bed: 1.0-2.0 mL sublingual
• At 2.0 mL: delivers 50mg CBN (dosage investigated in 2024 sleep literature)
• At 1.0 mL: delivers 25mg CBN (above threshold associated with reduced sleep disturbance)
• Evidence: CBN sleep [16][17], cannabis sleep review [17]

For Timor-Leste’s communities where sleep disorders are common due to stress, shift work, or health conditions, this provides a non-benzodiazepine option.

Anxiety and Stress

• Daytime functional relief: 0.3 mL raw sublingual — CBD and CBG address anxiety pathways without impairment
• Nighttime: 1.0 mL sublingual — full profile including CBN for sleep architecture
• Evidence: CBD anxiety [3], CBG pharmacology [7][8], limonene entourage [20]

Given Timor-Leste’s history of conflict and trauma, PTSD and anxiety affect many. This offers a tool for management without the sedation of pharmaceuticals.

General Titration Principle: Start Low, Go Slow

Begin with 0.25-0.5 mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors.

Safety, Quality, and Legal Compliance

Third-Party Lab Testing

Every batch undergoes comprehensive testing:

• Potency: HPLC/UHPLC analysis confirms every cannabinoid to ±2% accuracy
• Heavy metals: ICP-MS testing for arsenic, cadmium, lead, mercury below FDA limits
• Pesticides: 400+ compound screening via LC-MS/MS and GC-MS/MS
• Residual solvents: Headspace GC verification of FDA Class 3 limits (<5,000 ppm)
• Microbial: Comprehensive pathogen screening including E. coli, Salmonella, Aspergillus

Certificates of Analysis (COAs) are available on our website and included with international shipments to Timor-Leste.

Legal Requirements

• Age: 21+ for all RSO products
• THC content: All products contain less than 0.3% delta-9 THC; Farm Bill compliant; hemp-derived cannabinoids
• FDA disclaimer: Not evaluated by FDA; not intended to diagnose, treat, cure, or prevent any disease; consult healthcare provider before use; individual results may vary
• Safety warnings: May cause drowsiness or impairment; do not operate vehicles or machinery; consult physician if pregnant or nursing; keep out of reach of children
• Legal responsibility: Buyer responsibility to check Timor-Leste laws; OilWell assumes no legal responsibility for customer’s use or decarboxylation decisions; void where prohibited by law

Business Operations

• Location: 810 Richmond Avenue, Houston, TX 77006 (Montrose neighborhood)
• Hours: Monday-Thursday 10AM-7PM, Friday-Saturday 10AM-10PM, Sunday 10AM-4PM
• Established: 2019
• Annual revenue: ~$1M
• Google rating: Near 5.0 stars
• Licensing: Texas DSHS licensed
• Contact: (832) 416-2816, [email protected]
• Website: https://oilwellcbd.com/

All artwork, formulations, and packaging are created in-house in Houston using only our own recipes and ideas.

Competitive Comparison: Why OilWell for Timor-Leste

vs. Traditional Illegal RSO

Dimension	Traditional RSO	OilWell RSO
Cannabinoids	THC-only, variable	7 defined cannabinoids at specific ratios
Standardization	None	Lab-tested to ±2% accuracy
Solvents	Naphtha/isopropyl (toxic)	Solvent-free, food-grade MCT oil
Terpenes	Destroyed	Live terpenes at 5% with defined profile
Testing	None	Full panel COAs
THCa preservation	No	Yes, 1,500mg as separate ingredient
Delta-9 THC dominance	60-90%	Only 90mg total in bottle
Legal status	Illegal	Farm Bill compliant
Access in Timor-Leste	Not shippable	International shipping available
Patient control	None	You control decarboxylation
Cost	Black market pricing	$129.99 with open-source alternative

vs. Texas Medical Cannabis (TCUP)

TCUP requires a medical card with qualifying conditions (cancer, PTSD, epilepsy, autism, terminal illness, ALS, MS, seizure disorders, incurable neurodegenerative diseases). Less than 10,000 Texans actively use it.

OilWell requires only age 21+. No medical card. No qualifying conditions. We ship directly to Timor-Leste. Same product. Legal access.

vs. Hemp CBD-Only Products

Typical CBD RSO contains ~1,000mg total cannabinoids, mostly CBD. OilWell delivers 16,590mg total across seven cannabinoids. If you’re looking beyond single-molecule CBD, our multi-cannabinoid approach offers significantly broader therapeutic potential.

The OilWell Mission: More Than Products

OilWell Cannabis is more than a brand — it is a promise to our customers in Timor-Leste and worldwide that we will always strive to deliver the best, most thoughtful cannabis products available. We are not here to follow trends. We are here to set them.

As we continue to grow, our focus remains on maintaining the same level of integrity, creativity, and commitment that defined us from the day Bentley got up, walked across the room, and brought his ball to play.

Our mission is simple: make products with intent, answer directly, and never pretend cannabis is right for everyone. For our Timor-Leste community, this means honest education about what works, what doesn’t, and what might work for you. It means legal access to multi-cannabinoid formulations that respect both science and traditional plant wisdom. It means patient control over your own medicine. It means the recipe is free if you need it.

From Houston to Dili, from the Texas Medical Center to Timor-Leste’s community health posts, from a paralyzed dog named Bentley to every person searching for relief — this is OilWell Cannabis.

---